Skip to main content
. 2009 Jul 1;13(6):1059–1085. doi: 10.1111/j.1582-4934.2008.00676.x

Table 2.

Gastrointestinal cancer: nuclear expression patterns [a–d] of lamins (positive samples/total number of tested samples)

Tumour/method Lamins A and C Lamin B1
Oesophageal cancer: squamous/IPO 3/6 (a) 3/6 (a)
0/6 (c) 3/6 (c)
3/6 (d) 0/6 (d)
Oesophageal cancer: adenocarcinoma/IPO 0/2 (a) 1/2 (a)
1/2 (c) 0/2 (c)
1/2 (d) 1/2 (d)
Oesophageal cancer cell lines/PM 3/3 (b) nr
Gastric adenocarcinoma/IPO 1/8 (a) 2/8 (a)
3/8 (c) 2/8 (c)
4/8 (d) 4/8 (d)
Colonic adenocarcinoma/IPO 0/17 (a) 0/17 (a)
3/17 (c) 10/17(c)
14/17(d) 7/17 (d)
Colorectal cancer/IPO 463/656 (a) nr
193/656 (d)
Pancreatic cancer/IPO 3/3 (a) 3/3 (a)
Hepatocellular cancer/IPO* 5/5 (a) 5/5 (a)

IPO – Immunoperoxidase, PM – Protein microarrays.

(a) positive staining, (b) elevated staining/levels, (c) reduce staining/levels (d) no staining.

*

B type lamins were evaluated.